50432-65-0 Usage
Uses
Used in Pharmaceutical Industry:
4-chloro-2-methyl-1H-imidazo[4,5-c]pyridine is used as a building block for the synthesis of various pharmaceutical compounds. Its unique structure and potential to form hydrogen bonds make it a valuable component in the development of new drugs.
Used in Agrochemical Production:
4-chloro-2-methyl-1H-imidazo[4,5-c]pyridine is used as an intermediate in the production of agrochemicals. Its versatility and potential interactions with biological targets make it a useful component in the creation of effective agricultural products.
Used in Anti-Cancer Research:
4-chloro-2-methyl-1H-imidazo[4,5-c]pyridine has been studied for its potential use as an anti-cancer agent. Its ability to form hydrogen bonds and interact with biological targets suggests that it may have therapeutic applications in the treatment of cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 50432-65-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,4,3 and 2 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 50432-65:
(7*5)+(6*0)+(5*4)+(4*3)+(3*2)+(2*6)+(1*5)=90
90 % 10 = 0
So 50432-65-0 is a valid CAS Registry Number.
50432-65-0Relevant academic research and scientific papers
8-methyl derivatives of aristeromycin, neplanocin, 3-deazaneplanocin and related analogs
Yin, Xueqiang,Chen, Qi,Ye, Wei,Li, Chong,Schneller, Stewart W.
, p. 445 - 461 (2019/05/21)
The promising biological properties of 8-methyladenosine prompted a study of the related carbocyclic analogs based on aristeromycin and neplanocin. These target compounds have been prepared from strategically protected parent carbocyclic nucleoside derivatives or built up from suitable cyclopentanols and cyclopentenols. Several of these nucleosides were evaluated against a variety of RNA and DNA viruses to determine the potential of the 8-methyl series as a source for new antiviral agents. Encouraging results towards Epstein-Barr virus, cowpox, vaccinia virus, Ebola, and the flaviviruses (dengue and yellow fever) suggests more extensive studies.
